These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15533864)

  • 41. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV.
    Daskou M; Mu W; Sharma M; Vasilopoulos H; Heymans R; Ritou E; Rezek V; Hamid P; Kossyvakis A; Sen Roy S; Grijalva V; Chattopadhyay A; Kitchen SG; Fogelman AM; Reddy ST; Kelesidis T
    PLoS Pathog; 2022 Jan; 18(1):e1010160. PubMed ID: 34995311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.
    Datta G; Kramer PA; Johnson MS; Sawada H; Smythies LE; Crossman DK; Chacko B; Ballinger SW; Westbrook DG; Mayakonda P; Anantharamaiah GM; Darley-Usmar VM; White CR
    Biochem J; 2015 May; 467(3):517-27. PubMed ID: 25742174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.
    Vaziri ND; Moradi H; Pahl MV; Fogelman AM; Navab M
    Kidney Int; 2009 Aug; 76(4):437-44. PubMed ID: 19471321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic.
    Kimmel DW; Dole WP; Cliffel DE
    Biochem Biophys Res Commun; 2013 Feb; 431(2):181-5. PubMed ID: 23313489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide.
    Xu W; Qian M; Huang C; Cui P; Li W; Du Q; Yi S; Shi X; Guo Y; Zheng J; Liu D; Lin D
    Front Pharmacol; 2019; 10():817. PubMed ID: 31379582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.
    White CR; Datta G; Buck AK; Chaddha M; Reddy G; Wilson L; Palgunachari MN; Abbasi M; Anantharamaiah GM
    J Lipid Res; 2012 Aug; 53(8):1576-87. PubMed ID: 22589558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.
    Dunbar RL; Movva R; Bloedon LT; Duffy D; Norris RB; Navab M; Fogelman AM; Rader DJ
    Clin Transl Sci; 2017 Nov; 10(6):455-469. PubMed ID: 28795506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
    Navab M; Ruchala P; Waring AJ; Lehrer RI; Hama S; Hough G; Palgunachari MN; Anantharamaiah GM; Fogelman AM
    J Lipid Res; 2009 Aug; 50(8):1538-47. PubMed ID: 19225094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.
    Lu J; Gao J; Sun J; Wang H; Sun H; Huang Q; Zhang Y; Zhong S
    Front Pharmacol; 2023; 14():1106339. PubMed ID: 37576813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV.
    Daskou M; Sharma M; Mu W; Heymans R; Ritou E; Rezek V; Hamid P; Kossyvakis A; Sen Roy S; Grijalva V; Chattopadhyay A; Papesh J; Meriwether D; Kitchen SG; Fogelman AM; Reddy ST; Kelesidis T
    Metabolism; 2021 Nov; 124():154888. PubMed ID: 34509494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties.
    Liu Z; Cao Y; Liao XL; Ou ZJ; Mo ZW; Liu YF; Chen YT; Liu ZL; Gao JJ; Ning DS; Peng YM; Sorci-Thomas MG; Ou JS; Li Y
    J Cardiovasc Transl Res; 2024 Oct; ():. PubMed ID: 39412642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression.
    Peng M; Zhang Q; Cheng Y; Fu S; Yang H; Guo X; Zhang J; Wang L; Zhang L; Xue Z; Li Y; Da Y; Yao Z; Qiao L; Zhang R
    Oncotarget; 2017 Nov; 8(59):99693-99706. PubMed ID: 29245934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.
    Bloedon LT; Dunbar R; Duffy D; Pinell-Salles P; Norris R; DeGroot BJ; Movva R; Navab M; Fogelman AM; Rader DJ
    J Lipid Res; 2008 Jun; 49(6):1344-52. PubMed ID: 18323573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Natural inhibitors of viral replication of low molecular weight].
    Antonelli G; Calandra P; Facchini J; Baron S; Dianzani F
    G Ital Chemioter; 1985; 32(1):105-8. PubMed ID: 3841660
    [No Abstract]   [Full Text] [Related]  

  • 56. Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.
    Ruchala P; Navab M; Jung CL; Hama-Levy S; Micewicz ED; Luong H; Reyles JE; Sharma S; Waring AJ; Fogelman AM; Lehrer RI
    PLoS One; 2010 Apr; 5(4):e10181. PubMed ID: 20418958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice.
    Marino JS; Peterson SJ; Li M; Vanella L; Sodhi K; Hill JW; Abraham NG
    Nutr Diabetes; 2012 Mar; 2(3):e33. PubMed ID: 23169576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of methyl viologen on phospholipid metabolism in cultured human type 2 pneumocytes].
    Saito K
    Kokyu To Junkan; 1982 Nov; 30(11):1129-33. PubMed ID: 7167682
    [No Abstract]   [Full Text] [Related]  

  • 59. [Peptides associated with phospholipids in human serum. II. New attempt of separation].
    CHEFTEL RI; MORETTI J; POLONOVSKI J
    C R Seances Soc Biol Fil; 1957; 151(7):1332-4. PubMed ID: 13523897
    [No Abstract]   [Full Text] [Related]  

  • 60. Biomarkers for Lipid and Albumin Metabolism in Hospitalized Patients with Underlying Diseases and Community-Acquired Pneumonia Caused by Bacterial or SARS-CoV-2 Infection.
    Liu Z; Wang Q; Wang H; Li J; Yuan Y; Yi GZ
    J Inflamm Res; 2023; 16():1135-1145. PubMed ID: 36945318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.